Nautilus Biotechnology (NAUT)'s 30-day implied volatility (IV30) was 138.5% at the close on November 18, 2026, up from 122.9% the day before, against a 52-week range of 60.1% to 165.2%. Its 20-day historical volatility was 139.1%.
Data as of November 18, 2026.